Month |
Publication |
Title |
| December |
New Indian Express |
Orchid plans to increase headcount as it expands |
| October |
Business Line |
Orchid, Swedish co sign pact |
| October |
The Economic Times |
Orchid Chem inks deal with Biovitrum |
| October |
Business Line |
Orchid Chemicals net rises to Rs 29 cr |
| October |
The Economic Times |
Orchid net at Rs 29 cr |
| September |
Business Standard |
Orchid facilities get nod of UK regulator |
| September |
The Economic Times |
Orchid gets US nod for cefadroxil tablets |
| August |
The Economic Times |
Orchid gets US nod for new drug |
| August |
The Hindu |
Orchid buys out Bexel |
| August |
The Economic Times |
Orchid to focus on research |
| August |
The Economic Times |
Orchid set to acquire remaining Bexel stake |
| July |
The Economic Times |
Orchid net up at Rs 14.6 cr |
| July |
The Economic Times |
Orchid to buy out US co Bexel Pharma |
| June |
Business Standard |
Orchid ends molecular bio research JV in US |
| May |
Business Line |
Orchid gearing up for overseas buys |
| May |
Business Standard |
Orchid to raise Rs 890 cr via FCCBs, GDRs |
| May |
Business Line |
Orchid to raise Rs 900 cr |
| May |
Business Line |
Orchid targets 30 pc topline growth |
| April |
Business Standard |
Orchid Chem net up 17% |
| April |
Business Line |
Orchid Chemicals Q4 net up, to pay 30 pc |
| April |
The Economic Times |
Orchid launches generic drugs in US |
| March |
Business Standard |
Orchid in talks to license out diabetes molecule |
| February |
Business Standard |
Orchid in R&D pact with Pfizer |
| February |
The Economic Times |
Orchid Chem signs deal with Pfizer |
| February |
The Economic Times |
Orchid gets US nod for Cefoxitin |
| February |
The Economic Times |
Orchid to file 25 ANDAs in ’06 |
| February |
Business Standard |
Orchid to put 4 new molecules through human trials by Dec |
| January |
The Economic Times |
Orchid receives drug approval in US |
| January |
Business Line |
Orchid's net up five-fold; touches Rs 28.96 crore |
| January |
Business Standard |
|
| January |
The Hindu |
Orchid gets USFDA approval for Cefprozil |
